Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease.

    Hata M, Takayama T, Sezai A, Yoshitake I, Hirayama A, Minami K.

    Ann Thorac Surg. 2009 Nov;88(5):1440-4.PMID: 19853088 [PubMed - indexed for MEDLINE]Related articles

    2.

    The SLCO1B1*5 genetic variant is associated with statin-induced side effects.

    Voora D, Shah SH, Spasojevic I, Ali S, Reed CR, Salisbury BA, Ginsburg GS.

    J Am Coll Cardiol. 2009 Oct 20;54(17):1609-16.PMID: 19833260 [PubMed - indexed for MEDLINE]Related articles

    3.

    Statins for the prevention and treatment of infections: a systematic review and meta-analysis.

    Tleyjeh IM, Kashour T, Hakim FA, Zimmerman VA, Erwin PJ, Sutton AJ, Ibrahim T.

    Arch Intern Med. 2009 Oct 12;169(18):1658-67. Review.PMID: 19822822 [PubMed - indexed for MEDLINE]Related articles

    4.

    Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation.

    Waters DD, Ku I.

    J Am Coll Cardiol. 2009 Oct 6;54(15):1434-7.PMID: 19796736 [PubMed - indexed for MEDLINE]Related articles

    5.

    Statins in acute coronary syndromes: do the guideline recommendations match the evidence?

    Morrissey RP, Diamond GA, Kaul S.

    J Am Coll Cardiol. 2009 Oct 6;54(15):1425-33. Review.PMID: 19796735 [PubMed - indexed for MEDLINE]Related articles

    6.

    Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.

    Zhao SP, Peng DQ, Yu BL, Huo Y; CHILLAS investigators.

    Am Heart J. 2009 Oct;158(4):509-512.e1.PMID: 19781407 [PubMed - indexed for MEDLINE]Related articles

    8.

    Preinjury statin use is associated with a higher risk of multiple organ failure after injury: a propensity score adjusted analysis.

    Neal MD, Cushieri J, Rosengart MR, Alarcon LH, Moore EE, Maier RV, Minei JP, Billiar TR, Peitzman AB, Sperry JL; Inflammation and Host Response to Injury Investigators.

    J Trauma. 2009 Sep;67(3):476-82; discussion 482-4.PMID: 19741387 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).

    Cui Y, Watson DJ, Girman CJ, Shapiro DR, Gotto AM, Hiserote P, Clearfield MB.

    Am J Cardiol. 2009 Sep 15;104(6):829-34.PMID: 19733719 [PubMed - indexed for MEDLINE]Related articles

    10.

    Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.

    Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA; Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators.

    Am J Cardiol. 2009 Sep 15;104(6):798-804. Epub 2009 Jul 23.PMID: 19733714 [PubMed - indexed for MEDLINE]Related articles

    11.

    Fluvastatin and perioperative events in patients undergoing vascular surgery.

    Schouten O, Boersma E, Hoeks SE, Benner R, van Urk H, van Sambeek MR, Verhagen HJ, Khan NA, Dunkelgrun M, Bax JJ, Poldermans D; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

    N Engl J Med. 2009 Sep 3;361(10):980-9.PMID: 19726772 [PubMed - indexed for MEDLINE]Related articles

    12.

    Statin treatment equalizes long-term survival between patients with single and bilateral internal thoracic artery grafts.

    Carrier M, Cossette M, Pellerin M, Hébert Y, Bouchard D, Cartier R, Demers P, Jeanmart H, Pagé P, Perrault LP.

    Ann Thorac Surg. 2009 Sep;88(3):789-95; discussion 795.PMID: 19699899 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.

    Veselka J, Zemánek D, Hájek P, Malý M, Adlová R, Martinkovicová L, Tesar D.

    Am J Cardiol. 2009 Sep 1;104(5):630-3. Epub 2009 Jun 24.PMID: 19699335 [PubMed - indexed for MEDLINE]Related articles

    14.

    Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review.

    Liakopoulos OJ, Choi YH, Kuhn EW, Wittwer T, Borys M, Madershahian N, Wassmer G, Wahlers T.

    J Thorac Cardiovasc Surg. 2009 Sep;138(3):678-686.e1. Epub 2009 Jun 6. Review.PMID: 19698856 [PubMed - indexed for MEDLINE]Related articles

    15.

    Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?

    Connor A, Tomson C.

    BMJ. 2009 Aug 20;339:b2949. doi: 10.1136/bmj.b2949. No abstract available. PMID: 19696089 [PubMed - indexed for MEDLINE]Related articles

    16.

    Common drugs can harm elderly patients.

    Voelker R.

    JAMA. 2009 Aug 12;302(6):614-5. No abstract available. PMID: 19671895 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

    Xinwei J, Xianghua F, Jing Z, Xinshun G, Ling X, Weize F, Guozhen H, Yunfa J, Weili W, Shiqiang L.

    Am J Cardiol. 2009 Aug 15;104(4):519-24. Epub 2009 Jun 21.PMID: 19660605 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment.

    Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Takahashi H, Iida K, Matsumoto M, Washio T, Kumabe N, Hirayama A.

    Am J Cardiol. 2009 Aug 15;104(4):464-9. Epub 2009 Jun 24.PMID: 19660595 [PubMed - indexed for MEDLINE]Related articles

    19.

    Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease.

    Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC, Larsen ML, Lindahl C, Olsson AG, Tikkanen MJ, Waters DD, Pedersen TR; Steering Committees of IDEAL and TNT Trials.

    Am J Cardiol. 2009 Aug 15;104(4):459-63. Epub 2009 Jun 24.PMID: 19660594 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...